SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13G - Statement of Beneficial Ownership by Certain Investors:
SEC Accession No. 0001104659-19-075584
Filing Date
2019-12-23
Accepted
2019-12-23 16:07:03
Documents
1
Group Members
DECHENG CAPITAL MANAGEMENT III (CAYMAN), LLCXIANGMIN CUI

Document Format Files

Seq Description Document Type Size
1 SCHEDULE 13G tm1927294-1_sc13g.htm SC 13G 83871
  Complete submission text file 0001104659-19-075584.txt   85455
Mailing Address 1 EVERTRUST PLAZA 13TH FLOOR JERSEY CITY NJ 07302-6548
Business Address 1 EVERTRUST PLAZA 13TH FLOOR JERSEY CITY NJ 07302-6548 201-884-5485
SCYNEXIS INC (Subject) CIK: 0001178253 (see all company filings)

IRS No.: 562181648 | Fiscal Year End: 1231
Type: SC 13G | Act: 34 | File No.: 005-88127 | Film No.: 191306057
SIC: 2834 Pharmaceutical Preparations

Mailing Address UGLAND HOUSE, PO BOX 309 GRAND CAYMAN E9 KY1-1104
Business Address UGLAND HOUSE, PO BOX 309 GRAND CAYMAN E9 KY1-1104 345-949-8066
Decheng Capital China Life Sciences USD Fund III, L.P. (Filed by) CIK: 0001736814 (see all company filings)

IRS No.: 000000000 | State of Incorp.: E9 | Fiscal Year End: 1231
Type: SC 13G